Apoptosis May Have a Role in Etiopathogenesis of Obstetric Cholestasis.
- Conditions
- Pregnancy
- Registration Number
- NCT02192177
- Lead Sponsor
- Zekai Tahir Burak Women's Health Research and Education Hospital
- Brief Summary
Intrahepatic cholestasis of pregnancy is a disease specific to pregnancy period; especially late second and third trimester. We aimed to investigate the role of apoptosis in etiopathogenesis of obstetric cholestasis.
- Detailed Description
M30 (caspases cleaved Cytokeratin-18 (CK-18) fragment) is a specific apoptosis marker. We aimed to use it to evaluate the apoptotic process.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
- Late second or third trimester of pregnancy.
Exclusion Criteria
- Foreknown systemic diseases, multiple pregnancy, smoking cigarettes.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method M30 value as Unit per Liter. Four months.
- Secondary Outcome Measures
Name Time Method Percentage of delivery with cesarean section. Four months.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What role does apoptosis play in the etiopathogenesis of intrahepatic cholestasis of pregnancy as studied in NCT02192177?
How does caspase-cleaved cytokeratin-18 (M30) correlate with bile acid levels in obstetric cholestasis patients?
Are there specific molecular pathways linking apoptosis to liver dysfunction in late pregnancy?
What are the potential therapeutic implications of targeting apoptotic mechanisms in intrahepatic cholestasis of pregnancy?
How do findings from NCT02192177 compare to other observational studies on obstetric cholestasis biomarkers?
Trial Locations
- Locations (1)
Zekai Tahir Burak Maternity Teaching Hospital
🇹🇷Ankara, Turkey
Zekai Tahir Burak Maternity Teaching Hospital🇹🇷Ankara, TurkeyAli O ErsoyPrincipal Investigator